Form 4: Clover Health Investments Executive Karen Soares Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Karen Soares, General Counsel & Secretary of Clover Health Investments, reports the acquisition of restricted stock units (RSUs) and changes in beneficial ownership of Class A Common Stock.

Summary

  • On October 15, 2024, Karen Soares, General Counsel & Secretary of Clover Health Investments, acquired 450,955 shares of Class A Common Stock through a time-based restricted stock unit award (RSUs).
  • The price of the acquired shares was $0.
  • These RSUs vest over time, with 25% vesting on the first anniversary of the grant date (October 15, 2025), and the remaining RSUs vesting in twelve equal quarterly installments thereafter, fully vesting on October 15, 2028.
  • Following the transaction, Soares beneficially owns 1,556,244 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not convey any particular sentiment. It simply reports a transaction.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings and transactions of company executives.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it is a routine grant of equity compensation to an executive.

Key Dates

DateDescription
10/15/2024Date of earliest transaction: Acquisition of restricted stock units (RSUs).
10/15/2025First vesting date: 25% of RSUs vest.
10/15/2028Final vesting date: RSUs fully vested.
10/17/2024Date of signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.